Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé 15:43:01 03/09/2026 Varia. 5j. Varia. 1 janv.
1 872,00 GBX +0,56% Graphique intraday de GSK plc +3,05% +4,60%

Autres langues

15:38 Afternoon Meeting: La triple amenaza que se cierne sobre Wall Street
15:02 Wall Street's Triple Squeeze
13:11 FTSE 100 edges higher; oil rises above USD97
12:21 WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit
11:23 Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
10:54 Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%
09:47 Hutchmed Signs Cancer Treatment Licensing Agreement With GSK; Shares Rise Pre-Bell
08:57 LondonMetric investments; Jet2 eyes Main Market move
08:48 Morning Meeting: Comienzo sombrío de la temporada bursátil de otoño
08:32 Morning Meeting: Trüber Auftakt in den Börsenherbst
08:03 HUTCHMED Licenses Cancer Drug to GSK for Up to $1.30 Billion; Shares Up 12%
07:58 A gloomy start to the autumn trading season
07:45 HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
07:37 Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
06:55 UK Stocks-Factors to watch on September 3
06:38 Hutchmed Grants GSK Global Rights to KRAS-EGFR Antibody Conjugate Cancer Therapy
06:24 HUTCHMED (China) signs exclusive licensing deal with GSK for investigational cancer drug
01/09 Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data
01/09 European Stocks Close Mostly Lower in Tuesday Trading; Euro Area Inflation Surges in August
01/09 Global pharma companies that have publicly announced Trump drug pricing agreements
01/09 GSK advances mRNA flu vaccine to phase 3 after positive results
01/09 GSK überführt mRNA-Grippeimpfstoff in die nächste Studienphase
01/09 GSK Plans Phase 3 Trial for mRNA Flu Vaccine Candidate
01/09 UK Stocks-Factors to watch on September 1
01/09 UK house prices subdued; Bunzl lifts outlook
Aucun résultat pour cette recherche